Hospital medicines
by gross spend in the 2022/2023 financial year.
| Rank | Medicine | Therapeutic Group | 2023 $million |
|---|---|---|---|
| 1 | Infliximab | Immunosuppressants | $52.63 |
| 2 | Aflibercept | Immunosuppressants | $16.53 |
| 3 | Rituximab | Immunosuppressants | $8.90 |
| 4 | Iron (as ferric carboxymaltose) | Alimentary | $8.34 |
| 5 | Clostridium botulinum type A toxin | Musculoskeletal | $5.79 |
| 6 | Alteplase | Antithrombotics | $4.86 |
| 7 | Idarucizumab | Immunosuppressants | $4.26 |
| 8 | Enoxaparin sodium | Antithrombotics | $4.13 |
| 9 | Ustekinumab | Immunosuppressants | $3.69 |
| 10 | Tocilizumab | Immunosuppressants | $3.59 |
| 11 | Noradrenaline | Sympathomimetics | $2.88 |
| 12 | Ocrelizumab | Multiple Sclerosis Treatments | $2.84 |
| 13 | Levonorgestrel | Hormones | $2.71 |
| 14 | Sugammadex | Musculoskeletal | $2.44 |
| 15 | Paliperidone | Antipsychotics | $2.41 |
| 16 | Amphotericin B | Anti-infectives | $2.38 |
| 17 | Olanzapine | Antipsychotics | $2.17 |
| 18 | Lidocaine [Lignocaine] hydrochloride | Anaesthetics | $1.91 |
| 19 | Lenalidomide | Oncology | $1.79 |
| 20 | Heparin sodium | Blood and Blood Forming Organs | $1.76 |
| Total | $136.02 |